Bashour A M, Bloom G S
Department of Cell Biology and Neuroscience, University of Texas Southwestern Medical Center, Dallas, Texas 75235, USA.
J Biol Chem. 1998 Jul 31;273(31):19612-7. doi: 10.1074/jbc.273.31.19612.
58K was previously identified as a rat liver protein that binds microtubules in vitro and is associated with the cytoplasmic surface of the Golgi apparatus in vivo (Bloom, G. S., and Brashear, T. A. (1989) J. Biol. Chem. 264, 16083-16092). We now report that 58K is a formiminotransferase cyclodeaminase (FTCD), a bifunctional enzyme that catalyzes two consecutive steps in the modification of tetrahydrofolate to 5,10-methenyl tetrahydrofolate. Comparative immunoblotting using several monoclonal antibodies made against 58K and a polyclonal antibody made against a chicken liver protein (p60) with similar properties (Hennig, D., Scales, S. J., Moreau, A., Murley, L. L., De Mey, J., and Kreis, T. E. (1998) J. Biol. Chem. 273, 19602-19611) demonstrated precise co-purification of protein recognized by all antibodies through multiple fractionation steps, including gel filtration and ion exchange chromatography, and sucrose gradient ultracentrifugation. Eight peptides derived from 58K showed high sequence identity to amino acid sequences predicted by full length cDNA for p60 and porcine liver FTCD. Furthermore, purified 58K was associated with formiminotransferase and cyclodeaminase activities. Based on these collective results, 58K was concluded to be a rat liver version of FTCD. Microtubules assembled from brain tubulin, but not from liver tubulin, were able to bind rat liver FTCD. Binding to brain microtubules is suspected to occur via polyglutamates that are added post-translationally to tubulin in brain, which was shown to contain very low levels of FTCD, but not to tubulin in liver, which was determined to be the richest tissue source, by far, of FTCD. The physiological significance of the microtubule binding activity of FTCD is thus called into question, but an association of FTCD with the Golgi apparatus has now been established.
58K先前被鉴定为一种大鼠肝脏蛋白,它在体外与微管结合,在体内与高尔基体的细胞质表面相关联(布鲁姆,G.S.,和布拉希尔,T.A.(1989年)《生物化学杂志》264卷,16083 - 16092页)。我们现在报告58K是一种甲脒基转移酶环化脱氨酶(FTCD),一种双功能酶,它催化四氢叶酸修饰为5,10 - 亚甲基四氢叶酸过程中的两个连续步骤。使用几种针对58K制备的单克隆抗体以及一种针对具有相似性质的鸡肝蛋白(p60)制备的多克隆抗体进行的比较免疫印迹分析(亨尼希,D.,斯凯尔斯,S.J.,莫罗,A.,默利,L.L.,德梅伊,J.,和克雷斯,T.E.(1998年)《生物化学杂志》273卷,19602 - 19611页)表明,通过包括凝胶过滤、离子交换色谱和蔗糖梯度超速离心在内的多个分级分离步骤,所有抗体识别的蛋白质能够精确共纯化。从58K衍生的八个肽段与p60和猪肝FTCD的全长cDNA预测的氨基酸序列显示出高度的序列同一性。此外,纯化的58K与甲脒基转移酶和环化脱氨酶活性相关。基于这些综合结果,得出结论58K是大鼠肝脏版本的FTCD。由脑微管蛋白组装而成的微管,而非由肝微管蛋白组装而成的微管,能够结合大鼠肝脏FTCD。据推测,与脑微管的结合是通过在脑中微管蛋白翻译后添加的聚谷氨酸发生的,已表明脑中FTCD水平非常低,而肝中微管蛋白不含聚谷氨酸,肝被确定为迄今为止FTCD最丰富的组织来源。因此,FTCD与微管结合活性的生理意义受到质疑,但FTCD与高尔基体的关联现已确立。